StonvexLoading…
StonvexStonvexStonvexCore line items from MTW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.24B | $2.18B | $2.23B | $2.03B |
Operating Income | $53.80M | $51.80M | $92.40M | $-93.00M |
Net Income | $7.20M | $55.80M | $39.20M | $-123.60M |
EPS (Diluted) | $0.20 | $1.56 | $1.09 | $-3.51 |
Total Assets | $1.82B | $1.66B | $1.71B | $1.62B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $77.30M | $48.00M | $34.40M | $64.40M |
Free Cash Flow OCF − CapEx | $-15.30M | $3.50M | $-14.40M | $15.10M |
Shares Outstanding | 35.47M | 35.13M | 35.09M | 35.09M |